Tafas v. Dudas et al
Filing
135
MOTION for Summary Judgment by Triantafyllos Tafas. (Attachments: # 1 Proposed Order)(Baden-Mayer, Joanna)
Tafas v. Dudas et al
Doc. 135
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 1 of 6
UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA (Alexandria Division)
TRIANTAFYLLOS TAFAS, Plaintiff, v. JON W. DUDAS, in his official capacity as UnderSecretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, and the UNITED STATES PATENT AND TRADEMARK OFFICE, Defendants. CIVIL ACTION: 1:07cv846 (JCC/TRJ) and Consolidated Case (below)
SMITHKLINE BEECHAM CORPORATION, Plaintiff, v. JON W. DUDAS, in his official capacity as UnderSecretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, and the UNITED STATES PATENT AND TRADEMARK OFFICE, Defendants.
PLAINTIFF TRIANTAFYLLOS TAFAS' MOTION FOR SUMMARY JUDGMENT The Plaintiff, Dr. Triantafyllos Tafas ("Tafas"), by and through his undersigned attorneys, KELLEY DRYE & WARREN LLP, and pursuant to Rule 56 of the Federal Rules of Civil Procedure and Local Rule 56, hereby moves for summary judgment on all claims in his First Amended Complaint dated September 7, 2007 (the "Amended Complaint"). As set forth more particularly in Tafas' supporting memorandum of law, Tafas' supporting Declaration and the Declarations of Robert Fenili, Ph.D and Michael Rueda, Esq.,
1
Dockets.Justia.com
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 2 of 6
being filed along herewith, and based on the administrative record1 proffered by Defendant United States Patent and Trademark Office ("USPTO"), there are no genuine issues as to any material fact and Tafas is entitled to judgment as a matter of law. More particularly, this action is brought for declaratory judgment pursuant to 28 U.S.C. § 2201 et seq., and for judicial review under the Administrative Procedure Act ("APA"), 5 U.S.C. § 706, and the Regulatory Flexibility Act ("RFA"), 5 U.S.C. § 611. Tafas seeks the seeks the entry of summary judgment, inter alia, to: (1) permanently enjoin Defendants from implementing sections 1.75, 1.78, 1.104, 1.105, 1.110, 1.114, 1.142, 1.265 and 1.704 of certain new federal regulations promulgated by the USPTO, with an effective date of November 1, 2007, which were published at 72 Fed. Reg. 46716, 46835-43 (Aug. 21, 2007) and are to be codified at 37 C.F.R. Part 1 (the "Revised Rules"); (2) declaring the Revised Rules, in toto, null, void and without legal effect, inter alia, as being beyond the rule making power of the USPTO and as inconsistent with various federal statutes and the United States Constitution, including Article I, Section 8, Cl. 8 and the Fifth Amendment; and, (3) vacating and remanding the Revised Rules, including requiring Defendants to comply with the requirements of the APA, 5 U.S.C. § 553, and the RFA, 5 U.S.C. § 601 et seq., in promulgating any regulations in the future concerning the subject matter of the Revised Rules. As set forth more specifically in Tafas' memorandum of law, the Revised Rules should be permanently enjoined and declared null and void, among other reasons, because they: (1) violate and conflict, in whole or in part, with Sections 2, 41, 101, 102, 111, 112, 120, 121, 122, 131, 132, and 151 of the Patent Act (35 U.S.C. § 1 et seq.) and Sections 200-203 of the
1
Tafas has challenged the sufficiency and completeness of the USPTO's administrative record and Tafas' Objection to Magistrate Thomas Rawles Jones, Jr. Order denying discovery is still sub-judice with the Court. In the event that the Court should subsequently overrule Magistrate Jones and permit discovery, Tafas reserves the right to move to supplement his present summary judgment motion.
2
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 3 of 6
Bayh-Dole Act (35 U.S.C. § 200 et seq.), and exceed the USPTO's rule making authority delegated by Congress and under the U.S. Constitution; (2) violate and conflict with Sections 553(b)-(c) and 706(2) of the APA (5 U.S.C. §§ 553(b)-(c) and 706(2)), among other ways, because the USPTO purported to enact rules with retroactive effect; denied the public of its right to be informed of and meaningfully comment on "the terms or substance of the proposed rule"; by promulgating rules that are arbitrary, capricious, an abuse of discretion, otherwise not in accordance with law, contrary to Plaintiff's constitutional rights and in excess of the USPTO's statutory jurisdiction and authority; and (3) violate and conflict with the RFA, 5 U.S.C. §§ 601612, because the USPTO erroneously certified under RFA Section 605(b) that the Revised Rules would not have a significant impact on a substantial number of small businesses and, as such, failed to prepare a Final Regulatory Flexibility Analysis in contravention of RFA Section 604. CONCLUSION WHEREFORE, for all the foregoing reasons, as well as those set forth in Tafas' supporting memorandum of law and Declaration, and the Declarations of Robert Fenili, Ph.D and Michael Rueda, Esq., Plaintiff Tafas respectfully moves the Court to grant Tafas summary judgment in his favor, and to enter the proposed form of Order being submitted along herewith as follows, along with such other, further and different relief as the Court deems just, equitable and proper: Respectfully submitted, ___/s/ Joanna Baden-Mayer___________ Joanna Baden-Mayer (VSB # 67920) Joseph D. Wilson (VSB # 43693) Steven J. Moore, Esq. (pro hac vice) James E. Nealon, Esq. (pro hac vice) KELLEY DRYE & WARREN LLP Washington Harbor, Suite 400 3050 K Street, NW
3
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 4 of 6
Washington, DC 20007 Telephone: (202) 342-8400 Facsimile: (202) 342-8451 E-mail: jwilson@kelleydrye.com jbaden-mayer@kelleydrye.com jnealon@kelleydrye.com smoore@kelleydrye.com Counsel for Plaintiff Triantafyllos Tafas Of Counsel: William R. Golden Jr., Esq. KELLEY DRYE & WARREN LLP 101 Park Avenue New York, New York 10178-0002 Telephone: (212) 808-7992 Facsimile: (212) 808-7897 E-mail: wgolden@kelleydrye.com -- and --Shaun Gehan, Esq. David Frulla, Esq. KELLEY DRYE & WARREN LLP Washington Harbor, Suite 400 3050 K Street, NW Washington, DC 20007 Telephone: (202) 342-8400 Facsimile: (202) 342-8451 Email: sgehan@kelleydrye.com dfrulla@kelleydrye.com
Dated: December 20, 2007
4
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 5 of 6
CERTIFICATE OF SERVICE
I hereby certify that on December 20, 2007, I electronically filed the foregoing with the Clerk of the Court using the CM/ECF system, which will send a notification of such filing (NEF) to the following: Elizabeth Marie Locke Kirkland & Ellis LLP 655 15th Street, NW Suite 1200 Washington, DC 20005 Email: elocke@kirkland.com Craig Crandell Reilly Richard McGettingan Reilly & West PC 1725 Duke Street Suite 600 Alexandria, VA 22314 Email: craig.reilly@rmrwlaw.com Daniel Sean Trainor Kirkland & Ellis LLP 655 15th Street, NW Suite 1200 Washington, DC 20005 Email: dtrainor@kirkland.com Counsel for Plaintiffs SmithKline Beecham Corp. d/b/a GlaxoSmithKline, SmithKline Beecham PLC, and Glaxo Group Limited, d/b/a GlaxoSmithKline Thomas J. O'Brien Morgan, Lewis & Bockius 1111 Pennsylvania Avenue, NW Washington, DC 20004 Email: to'brien@morganlewis.com Counsel for Putative Amicus American Intellectual Property Lawyers Association Dawn-Marie Bey Kilpatrick Stockton LLP 700 13th Street NW Suite 800 Washington, DC 20005 Email: dbey@kslaw.com Counsel for Putative Amicus Hexas, LLC, The Roskamp Institute, Tikvah Therapeutics, Inc. James Murphy Dowd Wilmer Cutler Pickering Hale & Dorr LLP 1455 Pennsylvania Avenue NW Washington, DC 20004 Email: james.dowd@wilmerhale.com Counsel for Putative Amicus Pharmaceutical Research and Manufacturers of America Randall Karl Miller Arnold & Porter LLP 1600 Tysons Blvd Suite 900 McLean, VA 22102 Email: randall_miller@aporter.com Counsel for Putative Amicus Biotechnology Industry Organization Rebecca M. Carr Pillsbury Winthrop Shaw Pittman, LLP 2300 N Street, NW Washington, DC 20037 Email: Rebecca.carr@pillsburylaw.com Scott J. Pivnick Pillsbury Winthrop Shaw Pittman 1650 Tysons Boulevard McLean, Virginia 22102-4856 Email: Scott.pivnick@pillsburylaw.com Counsel for Putative Amicus Elan Pharmaceuticals, Inc. Robert E. Scully Jr. Stites & Harbison PLLC 1199 North Fairfax Street, Suite 900 Alexandria, Virginia 22314 (703) 739-4900 Fax: (703) 739-9577 Email: rscully@stites.com Counsel for Putative Amicus Curiae Human Genome Sciences, Inc.
Case 1:07-cv-00846-JCC-TRJ
Document 135
Filed 12/20/2007
Page 6 of 6
Matthew Schruers Computer & Communications Industry Association 900 17th Street, NW, Suite 1100 Washington, DC 20006 Tel.: (202) 7830070 Fax: (202) 7830534 Email: mailto:mschruers@ccianet.org mschruers@ccianet.org Counsel for Putative Amici Curiae Public Patent Foundation, Computer & Communications Industry Association, AARP, Consumer Federation of America, Essential Action, Foundation for Taxpayer and Consumer Rights, Initiative for Medicines, Access & Knowledge, Knowledge Ecology International, Prescription Access Litigation, Public Knowledge, Research on Innovation, and Software Freedom Law Center
Charles Gorenstein Michael K. Mutter Birch, Stewart, Kolasch and Birch, LLP 8110 Gatehouse Rd., Suite 100 East Falls Church, Virginia 22042 Email: cg@bskb.com Counsel for Putative Amicus Intellectual Property Institute of the William Mitchell College of Law Lauren A. Wetzler Assistant United States Attorney Justin W. Williams U.S. Attorney's Building 2100 Jamieson Avenue Alexandria, Virginia 22134 Tel: (703) 299-3752 Fax: (703) 299-3983 Email: Lauren.Wetzler@usdoj.gov Counsel for All Defendants
___/s/ Joanna Baden-Mayer__________ Joanna Baden-Mayer (VSB # 67920) KELLEY DRYE & WARREN LLP Washington Harbor, Suite 400 3050 K Street, NW Washington, DC 20007 Telephone: (202) 342-8400 Facsimile: (202) 342-8451 E-mail: jbaden-mayer@kelleydrye.com Counsel for Plaintiff Triantafyllos Tafas
6
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?